19.73
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt OPCH?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$19.52
Offen:
$19.62
24-Stunden-Volumen:
1.22M
Relative Volume:
0.46
Marktkapitalisierung:
$3.10B
Einnahmen:
$5.67B
Nettoeinkommen (Verlust:
$206.19M
KGV:
15.43
EPS:
1.2781
Netto-Cashflow:
$210.53M
1W Leistung:
-0.58%
1M Leistung:
-31.60%
6M Leistung:
-30.29%
1J Leistung:
-40.67%
Option Care Health Inc Stock (OPCH) Company Profile
Firmenname
Option Care Health Inc
Sektor
Branche
Telefon
312 940 2443
Adresse
3000 LAKESIDE DR, BANNOCKBURN, IL
Compare OPCH vs HCA, THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
OPCH
Option Care Health Inc
|
19.73 | 3.07B | 5.67B | 206.19M | 210.53M | 1.2781 |
|
HCA
Hca Healthcare Inc
|
425.83 | 93.84B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
195.40 | 16.94B | 21.46B | 2.65B | 3.35B | 19.23 |
|
DVA
Davita Inc
|
200.36 | 12.82B | 13.84B | 1.10B | 1.49B | 10.42 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.18 | 11.60B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
EHC
Encompass Health Corp
|
107.06 | 10.58B | 6.07B | 793.80M | 464.40M | 5.9914 |
Option Care Health Inc Stock (OPCH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-11 | Eingeleitet | Stephens | Overweight |
| 2025-10-02 | Eingeleitet | TD Cowen | Hold |
| 2025-04-30 | Hochstufung | UBS | Neutral → Buy |
| 2025-01-23 | Hochstufung | Jefferies | Hold → Buy |
| 2025-01-13 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-12-05 | Eingeleitet | UBS | Neutral |
| 2024-11-04 | Herabstufung | Goldman | Buy → Neutral |
| 2024-10-31 | Herabstufung | Jefferies | Buy → Hold |
| 2024-10-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-07-16 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-02-27 | Fortgesetzt | Jefferies | Buy |
| 2021-07-19 | Hochstufung | Goldman | Neutral → Buy |
| 2021-01-22 | Eingeleitet | Deutsche Bank | Buy |
| 2021-01-11 | Eingeleitet | JP Morgan | Overweight |
| 2020-12-15 | Eingeleitet | Goldman | Neutral |
| 2020-06-24 | Eingeleitet | BofA/Merrill | Buy |
Alle ansehen
Option Care Health Inc Aktie (OPCH) Neueste Nachrichten
What Option Care Health (OPCH)'s Guidance Cut and Insider Buying Signal Means For Shareholders - simplywall.st
Option Care Health forecasts 2026 revenue of $5.675B-$5.775B while maintaining EBITDA of $480M-$505M - MSN
Staley Capital Advisers Inc. Sells 75,000 Shares of Option Care Health, Inc. $OPCH - MarketBeat
Option Care Health (OPCH) price target decreased by 28.18% to 29.38 - MSN
Rosen Law Firm Encourages Option Care Health, Inc. Investors to I - The National Law Review
Rosen Law Firm Encourages Option Care Health, Inc. Investors to Inquire About Securities Class Action Investigation – OPCH - The Joplin Globe
Option Care Health, Inc. (OPCH) Investigation: Bronstein, Gewirtz - The National Law Review
Leeward Investments LLC MA Purchases 64,868 Shares of Option Care Health, Inc. $OPCH - MarketBeat
OPCH Stock Price, Quote & Chart | OPTION CARE HEALTH INC (NASDAQ:OPCH) - ChartMill
Number of shareholders of Option Care Health, Inc. – NASDAQ:OPCH - TradingView
OPCH SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations - GlobeNewswire Inc.
Option Care Health, Inc. (OPCH) Presents at Bank of America Global Healthcare Conference 2026Slideshow - Seeking Alpha
Bronstein, Gewirtz & Grossman, LLC Is Investigating Option Care H - The National Law Review
Independent Director of Option Care Health Picks Up 49% More Stock - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages Option Care Health - The National Law Review
OPCH Investor Alert: Levi & Korsinsky Investigates Option Care Health (OPCH) for Potential Securities Fraud - PR Newswire
Option Care Health (NASDAQ:OPCH) Stock Rating Lowered by Zacks Research - MarketBeat
OPTION CARE HEALTH, INC. INVESTOR ALERT: Kirby McInerney LLP Anno - The National Law Review
OPTION CARE HEALTH, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud - Business Wire
Transcript : Option Care Health, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10 - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Encourages Option Care Health, Inc. (OPCH) Investors to Inquire about Securities Investigation - ACCESS Newswire
A Director Keeps Buying OPCH as It Falls — and the Timing Is His Own - Yahoo Finance
Option Care Health Highlights Growth Strategies and Industry Trends at 2026 Bank of America Global Healthcare Conference - Minichart
Option Care Health Highlights 2026 Growth and Capital Priorities - TipRanks
Option Care Health to Present at Bank of America Health Care Conference, Posts Investor Deck - TradingView
Option Care Health (NASDAQ: OPCH) outlines 2026 growth focus - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Option Care Health, Inc. (OPCH) And Encourages Investors to Reach Out - ACCESS Newswire
Option Care Health, Inc. (OPCH) Stock Analysis: Exploring A 42% Upside Potential - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Option Care Health, Inc. (OPCH) And Encourages Stockholders to Reach Out - ACCESS Newswire
Investigation Alert: Option Care Health, Inc. (OPCH) Under ScrutinyContact Levi & Korsinsky for Details - TMX Newsfile
A Look At Option Care Health (OPCH) Valuation After Guidance Cut And Legal Investigations - Yahoo Finance
UBS Group AG Has $29.60 Million Position in Option Care Health, Inc. $OPCH - MarketBeat
How Investors May Respond To Option Care Health (OPCH) Revenue Guidance Cut And Chronic Therapy Headwinds - Sahm
Bronstein, Gewirtz & Grossman, LLC Is Investigating Option Care Health, Inc. (OPCH) And Encourages Stockholders to Connect - ACCESS Newswire
Van Berkom & Associates Acquires $51.54 Million Stake in Option Care Health - IndexBox
2026-05-08 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Option Care Health, Inc. (OPCH) And Encourages Stockholders to Connect | NDAQ:OPCH | Press Release - Stockhouse
Ambulatory Infusion Center Market to Boom Worldwide - openPR.com
Option Care Health, Inc. (NASDAQ:OPCH) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Insider Buying: Timothy Sullivan Acquires Shares of Option Care Health Inc (OPCH) - GuruFocus
Insider Buying: Option Care Health (NASDAQ:OPCH) Director Acquires 24,154 Shares of Stock - MarketBeat
This Healthcare Stock Fell 24% After Earnings. One Fund Bought $51 Million Before the Drop - The Motley Fool
Option Care Health Insider Bought Shares Worth $499,671, According to a Recent SEC Filing - marketscreener.com
Director at Option Care Health (OPCH) buys 24,154 company shares - Stock Titan
INVESTOR ALERT: Investigation of Option Care Health, Inc. (OPCH) announced by Holzer & Holzer, LLC - GlobeNewswire
OPCH SHAREHOLDER INVESTIGATION: Levi & Korsinsky - GlobeNewswire
Option Care Health Investors Should Contact Block & Leviton to Possibly Recover Losses - TMX Newsfile
Swedbank AB Sells 55,532 Shares of Option Care Health, Inc. $OPCH - MarketBeat
The Top 5 Analyst Questions From Option Care Health’s Q1 Earnings Call - The Globe and Mail
Option Care Health Price Target Cut to $485.00/Share by Morgan Stanley - Moomoo
Option Care Health faces fraud probe after cutting 2026 guidance, shares drop 26%. - Pluang
OPCH Investors Have Opportunity to Join Option Care Health, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
Finanzdaten der Option Care Health Inc-Aktie (OPCH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Option Care Health Inc-Aktie (OPCH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| KRAEMER HARRY M JANSEN JR | Director |
May 04 '26 |
Buy |
21.41 |
36,610 |
783,773 |
450,000 |
| Sethna Meenal | Chief Financial Officer |
May 04 '26 |
Buy |
20.16 |
16,225 |
327,075 |
98,337 |
| RADEMACHER JOHN CHARLES | Chief Executive Officer |
May 04 '26 |
Buy |
21.18 |
12,500 |
264,706 |
695,152 |
| Pate R Carter | Director |
Feb 27 '26 |
Sale |
32.05 |
30,287 |
970,620 |
11,623 |
| Bavaro Michael | Chief Human Resources Officer |
Feb 27 '26 |
Sale |
33.00 |
6,000 |
198,000 |
33,249 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):